Edwards Lifesciences Corp. (EW) Tops Q2 EPS by 2c; Guides Q3 Below the Street
Tweet Send to a Friend
Edwards Lifesciences Corp. (NYSE: EW) reported Q2 EPS of $0.67, $0.02 better than the analyst estimate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
